Dipeptidyl-peptidase-IV inhibition augments postprandial lipid mobilization and oxidation in type 2 diabetic patients. [electronic resource]
Producer: 20090407Description: 846-52 p. digitalISSN:- 1945-7197
- Adamantane -- analogs & derivatives
- Adipose Tissue -- metabolism
- Adult
- Aged
- Cross-Over Studies
- Diabetes Mellitus, Type 2 -- drug therapy
- Dipeptidyl-Peptidase IV Inhibitors -- pharmacology
- Double-Blind Method
- Female
- Glucagon-Like Peptide 1 -- physiology
- Humans
- Hypoglycemic Agents -- pharmacology
- Lipid Mobilization -- drug effects
- Male
- Middle Aged
- Muscle, Skeletal -- metabolism
- Nitriles -- pharmacology
- Norepinephrine -- blood
- Oxidation-Reduction
- Postprandial Period -- physiology
- Pyrrolidines -- pharmacology
- Vildagliptin
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.